Cytori Therapeutics Press Release

Cytori Therapeutics Press Release

Cytori Therapeutics, a company which is focusing much of its research on stem cells derived from adipose tissue (fat), yesterday issued a press release about an animal study on fat-derived stem cells in treatment of heart attacks. In the study, 17 laboratory animals were given either injections of their own adipose stem and regenerative cells (treated) or a saline injection (control) via catheter into the artery at the site of the heart attack. After eight weeks, there was a statistically significant reduction in the perfusion defect, which is the area of the heart deprived of oxygen as a result of the infarct. A corresponding benefit was observed by the improvement in ejection fraction, a common measure of the heart's pumping efficiency.

The study was significant in that the cells came directly from the subject animals themselves and were not cultured in a laboratory. Cytori’s president said they were starting an application to initiate European clinical trials next year.